The aim of the present study was to test whether high levels of activated Notch1 can induce a shift of driver dependence, from EGFR to Notch1, in oncogene-driven NSCLC, and thus causing resistance to EGFR inhibitors. This evidence concerns the gene NOTCH1 and non-small cell lung carcinoma.